Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Anticancer Research|October 25, 2017
New Drug Combination Strategies in Melanoma: Current Status and Future DirectionsAhmad Najem, Mohammad Krayem, Anne Perdrix, et al.
Oncotarget|August 31, 2018
Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanomaMohammad Krayem, Ahmad Najem, Fabrice Journe, et al.
Cells|April 12, 2022
Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of MelanomaAhmad Najem, Laura Soumoy, Malak Sabbah, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 25, 2018
Insights into inflammatory priming of mesenchymal stromal cells: functional biological impactsMehdi Najar, Mohammad Krayem, Makram Merimi, et al.
Frontiers in Oncology|December 6, 2021
Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy ResearchMorgane M Cogels, Redouane Rouas, Ghanem E Ghanem, et al.
Cells|July 29, 2023
Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted TherapiesAhmad Najem, Mohammad Krayem, Serena Sabbah, et al.
Biology|August 14, 2020
Toad Venom Antiproliferative Activities on Metastatic Melanoma: Bio-Guided Fractionation and Screening of the Compounds of Two Different VenomsLaura Soumoy, Mathilde Wells, Ahmad Najem, et al.
Cancers|April 23, 2022
The Road to Dissemination: The Concept of Oligometastases and the Barriers for Widespread DiseaseHamza AlGhamdi, Jennifer Dhont, Mohammad Krayem, et al.
Frontiers in Oncology|January 24, 2022
Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve TreatmentsTycho de Bakker, Fabrice Journe, Géraldine Descamps, et al.
European Journal of Cancer (Oxford, England : 1990)|July 25, 2017
P53 and MITF/Bcl-2 identified as key pathways in the acquired resistance of NRAS-mutant melanoma to MEK inhibitionAhmad Najem, Mohammad Krayem, François Salès, et al.
Pageof 4